Special Issue "Breast Cancers: Pathology and Biomarkers"

Guest Editor
Prof. Dr. Sandip Kumar SenGupta
Department of Pathology & Molecular Medicine, Queen's University, Canada
E-Mail: sengupts@kgh.kari.net
Phone: +1 613 549 6666 ext. 4164
Fax: +1 613 548 6076
Interests: breast cancer pathology; immunohistochemistry; prognostic and predictive factors; biomarkers

Dear Colleagues,

A major challenge in the clinical management of breast cancer is the accurate prognostication of clinical outcome and reliable prediction of which subgroups of patients will benefit (or not) from systemic treatment. Basic discoveries in cancer biology have identified key signaling pathways that drive malignant progression in breast cancer, and panels of bio-markers that assess their activation.  Recently, gene expression profiling has led to the discovery of molecular biomarker sets that define breast cancer subtypes which are associated with different prognoses and are correlated with previously identified clinical bio-markers.  In addition, distinct molecularly defined classes of tumor stroma have been associated with tumor subtypes, and have been found to enhance prognostic power. Mutational analysis and micro-RNA profiling also provide new dimensions for prognosis and prediction of treatment response. Through this special issue of Cancers dedicated towards breast cancer pathology and biomarkers, we are pleased to accept manuscripts for publication which will move us forward in our collective goal of providing optimal, personalized medical care for patients with breast cancer.

Prof. Dr. Sandip Kumar SenGupta
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

• breast pathology
• immunohistochemistry
• predictive markers
• prognostic markers
• breast cancer
• personalized medicine
• micro RNA
• signaling pathways
• gene expression profiling